| RESERVED AREA | LANGUAGE

Lung Cancer Study Group

Role of systemic therapy

Today we remember the Spring Meeting with comments from Dr. Daniel Coutinho, pulmonologist at the Centro Hospitalar de Vila Nova de Gaia e Espinho (CHVNGE) and member of the Scientific Committee of the GECP, on the theme “Role of systemic therapy of the CPNCP with genomic alterations”.

The specialist comments that “the therapies that currently exist, especially the third-generation therapies, represent a very high degree of penetration at the level of the central nervous system, providing good results in controlling the disease”.

With regard to the role of local treatment, Dr. Daniel Coutinho mentions that “unfortunately there are still no answers because there are few trials taking place in the area, so this management must always be done based on a multidisciplinary consultation”.

Watch the video and get to know the expert’s opinion.

Posted in entrevista, notícias, reunião, vídeo
©2022 Copyright GECP